ML16083A106
From kanterella
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Letter Sequence Request | |
|---|---|
TAC:MF6138, (Open) | |
Initiation Results
Other: ML15210A112, ML15210A117, ML15210A120, ML15210A122, ML15210A124, ML15271A005, ML15271A014, ML16033A179, ML16033A180, ML16344A054, ML16344A055 | |
MONTHYEARML15210A1202015-07-20020 July 2015
[Table View]Attachment 3 - Northwest Medical Isotopes, LLC - Part Two, Construction Permit Application, Chapter 5 Through Chapter 8 Project stage: Other ML15210A1172015-07-20020 July 2015 Attachment 3 - Northwest Medical Isotopes, LLC - Part Two, Construction Permit Application, Chapter 3 Through Chapter 4 Project stage: Other ML15210A1242015-07-20020 July 2015 Attachment 3 - Northwest Medical Isotopes, LLC - Part Two, Construction Permit Application, Chapter 13, Part 1 of 2 Project stage: Other ML15210A1122015-07-20020 July 2015 Attachment 3 - Northwest Medical Isotopes, LLC - Part Two, Construction Permit Application, General Information Per 10 CFR 50.33, Filing Free Required by 10 CFR 50.30(e) and 10 CFR 170.21, Classified Information Agreement Per 10 CFR 50.37, Project stage: Other ML15210A1222015-07-20020 July 2015 Attachment 3 - Northwest Medical Isotopes, LLC - Part Two, Construction Permit Application, Chapter 13, Part 2 of 2 Project stage: Other ML15210A1142015-07-20020 July 2015 NRC Project No. 0803 - Northwest Medical Isotopes, LLC, Submittal of Part 2 Construction Permit Application for a Radioisotope Production Facility Project stage: Request ML16344A0552015-08-29029 August 2015 NWMI-2015-CSE-008, Nwmi Preliminary Criticality Safety Evaluation: Hot Cell Uranium Purification (Recovery and Recycle) (Rev. a) (Public Version) Project stage: Other ML15271A0052015-10-28028 October 2015 FRN - Northwest Medical Isotopes, LLC, Construction Permit Application Part Two: Acknowledgement of Receipt and Availability Project stage: Other ML15271A0142015-11-0505 November 2015 Northwest Medical Isotopes, LLC - Acknowledgement of Receipt and Availability, Application for Construction Permit Part Two - Letter Project stage: Other ML15348A0212015-12-24024 December 2015 FRN - Northwest Medical Isotopes, LLC - Acceptance for Docketing of Part Two of the Application for a Production Facility Construction Permit Project stage: Acceptance Review ML16048A5542016-02-17017 February 2016 Rev 9 Mo-99 Overview and Status Slides No Notes Project stage: Request ML16083A1062016-02-18018 February 2016 Transcript of Public Meeting with Northwest Medical Isotopes on February 18, 2016, Pages 1-176 Project stage: Request ML16056A1222016-03-28028 March 2016 Northwest Medical Isotopes LLC - Request for Additional Information Regarding Application for Construction Permit (MF6135 and MF6138) Project stage: RAI ML16083A1072016-03-29029 March 2016 February 18, 2016 Summary of Public Meeting with Northwest Medical Isotopes Project stage: Meeting ML16123A1192016-04-25025 April 2016 Northwest Medical Isotopes, LLC - Responses to the NRC Environmental Request for Additional Information - Letter Dated March 28, 2016 Project stage: Request ML16033A1792016-05-18018 May 2016 FRN Northwest Medical Isotopes LLC - Notice of Hearing, Opportunity to Petition for Leave to Intervene, and Order Imposing Procedures Regarding Application for Construction Permit Project stage: Other ML16033A1802016-05-24024 May 2016 Letter to Northwest Medical Isotopes LLC - Notice of Hearing, Opportunity to Petition for Leave to Intervene, and Order Imposing Procedures Regarding Application for Construction Permit Project stage: Other ML16216A1862016-06-0202 June 2016 University of Missouri-Columbia Research Reactor - Mo-99 Presentation (Public) Project stage: Request ML16210A3052016-07-18018 July 2016 Northwest Medical Isotopes, LLC, Response to Request for Additional Information Regarding Chapters 4, 13, and 19 of the Preliminary Safety Analysis Report and Environmental Review Project stage: Response to RAI ML16270A3772016-09-0101 September 2016 Northwest Medical Isotopes, LLC, Response to Environmental Request for Additional Information - Additional Clarification on POSA3-1A, POSA3-2A, POSA3-3A, NOI3-IB, and PA3-1 Project stage: Request ML16236A0132016-09-29029 September 2016 Northwest Medical Isotopes, LLC - Request for Additional Information Regarding Application for Construction Permit Project stage: RAI ML16288A4882016-10-20020 October 2016 Summary of Public Meeting with Northwest Medical Isotopes, LLC Project stage: Meeting ML16344A0542016-11-28028 November 2016 NWMl-2014-RPT-006, Northwest Medical Isotopes, LLC - MCNP 6.1 Validations with Continuous Energy ENDF/B-VII.1 Cross-Sections (Rev. 0) (Public Version) Project stage: Other ML16344A0522016-11-28028 November 2016 Northwest Medical Isotopes, LLC - Responses to the U.S. Nuclear Regulatory Commission Regarding the Preliminary Safety Analysis Report Request for Additional Information Project stage: Request ML16344A0532016-11-28028 November 2016 Northwest Medical Isotopes, LLC - Response to the U.S. Nuclear Regulatory Commission Request for Additional Information Regarding the Preliminary Safety Analysis Report and Environmental Review Project stage: Request ML17093A6612017-03-0606 March 2017 Northwest Medical Isotopes, LLC Responses to the U.S. Nuclear Regulatory Commission Environmental Request for Additional Information - Letter Dated January 25, 2017 Project stage: Request ML17069A4082017-03-29029 March 2017 Northwest Medical Isotopes, LLC Request for Additional Information Regarding Application for Construction Permit Project stage: RAI ML17128A0662017-04-28028 April 2017 Northwest Medical Isotopes, LLC Response to the NRC Regarding the Request for Additional Information Regarding Application for Construction Permit (Letter Dated March 29, 2017) Project stage: Request ML17128A0672017-04-28028 April 2017 NWMI-2017-RAI-002, Rev. 0, Response to the U.S. Nuclear Regulatory Commission Northwest Medical Isotopes, LLC - Request for Additional Information Regarding Application for Construction Permit Project stage: Request ML17157B4112017-06-0202 June 2017 Northwest Medical Isotopes, LLC, Transmittal of Revision 2 of NWMI-2014-RPT-006, MCNP 6.1 Validations with Continuous Energy ENDF/B-VIL.1 Cross-Sections Project stage: Request ML17221A2012017-08-0505 August 2017 Attachment 3 to NWMI-2013-021, Rev. 2, Chapter 6.0 - Engineered Safety Features Construction Permit Application for Radioisotope Production Facility to Chapter 11.0 - Radiation Protection and Waste Management Project stage: Request ML17265A0462017-09-19019 September 2017 Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit Project stage: Request ML17265A0472017-09-19019 September 2017 Response to the U.S. Nuclear Regulatory Commission, Northwest Medical Isotopes, LLC - Request for Additional Information Regarding Preliminary Safety Analysis Report, Construction Permit Application Project stage: Request ML17262A1112017-09-21021 September 2017 Northwest Medical Isotopes, LLC Request for Additional Information Regarding Application for Construction Permit Project stage: RAI ML17283A1092017-09-28028 September 2017 Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit (TAC No. MF6138), Docket No. 50-609, Dated September 18, 2017 Project stage: Request 2016-05-18 |
| ML16083A106 | |
| Person / Time | |
|---|---|
| Site: | Northwest Medical Isotopes |
| Issue date: | 02/18/2016 |
| From: | Michael Balazik NRC/NRR/DPR/PRLB |
| To: | |
| Shared Package | |
| ML16083A110 | List: |
| References | |
| NRC-2177 | |
| Download: ML16083A106 (177) | |
Similar Documents at Northwest Medical Isotopes | |
|---|---|
Text
Retrieved from "https://kanterella.com/w/index.php?title=ML16083A106&oldid=5174774"